Contact Person : Margo Gantner ; Last Date for the submission of abstract : 13/11/2018; The 4th Oncolytic Virotherapy Summit is dedicated to improving the commercial success of oncolytic viruses, in stand-alone and combination therapies.As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy.